Pilot implementation programs have been conducted in several African countries, including Ghana, Kenya, and Malawi. These programs aim to evaluate the vaccine’s real-world effectiveness, safety, and feasibility. The data gathered from these pilot studies will help inform future decisions on broader implementation.
